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Angiogram negative subarachnoid hemorrhage in the setting of sexual intercourse 
and chronic cannabis use 
 
Abstract 
 
Etiology of unprovoked subarachnoid hemorrhage (SAH) is predominantly from cerebral aneurysm 
rupture and manifests classically as a thunderclap headache. Orgasmic cephalgia may herald SAH 
given that 4-12% of SAH sufferers were found to have engaged in prior sexual activity.1 
Precipitating causes of SAH leading to aneurysmal rupture may be the rise in blood pressure caused 
by physical activity. A CT angiogram (CTA) is used to reveal a source of the bleed but 
occasionally this is normal, and is labelled angiogram- negative SAH or non-aneurysmal SAH. In 
those cases digital subtraction imaging (DSA, conventional angiogram) is needed for verification. 
Herein we discuss an instance of angiogram negative SAH which occurred after sexual activity in a 
young male with a chronic cannabis habit. 
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Case Report 
 
A 26-year-old African American male with no significant past medical history presented with 
complaints of a severe occipital headache that started during sexual intercourse and was non-
radiating. His mother passed away from stroke in her thirties and father’s medical history was 
unknown. His siblings had no medical problems. He had used his usual dose of marijuana daily for 
the last 3 years and smoked 3-4 cigarettes per day. He was allergic to iodine and was not on any 
medications. He had no intake of alcohol or any toxin exposures. Patient described the headache as 
throbbing and graded it as 8/10 in intensity. He denied nausea, vomiting, visual disturbance, chest 
pain, palpitations, numbness, tingling, weakness or gait difficulties. He was afebrile, heart rate was 
58, blood pressure 117/68. His neurologic exam was normal, including cranial nerves, strength 
reflexes, coordination, sensation, gait and station. CT head (Figure 1) showed an acute subarachnoid 
hemorrhage within basilar cisterns and right temporal lobe along the sylvian fissure with no 
hydrocephalus. Neurology recommended BP goal <140/90 and admission to ICU for further 
management. He was started on nimodipine 60mg q4h for 21 days (7 of which he spent as 
inpatient). Laboratory testing showed a normal white blood cell count, electrolytes, liver functions, 
and urine drug screen showed presence of cannabinoids. Patient’s headache went down to 3/10 
intensity in the first 12 hours and after that he was asymptomatic. CTA head (Figure 2) showed no 
evidence of arteriovenous malformation (AVM) or arterio-venous (AV) fistula or intracranial 
aneurysm. DSA showed that there was mild hypervascularity in the right temporal region, possibly 
from an AVM. Dural venous sinuses were patent throughout. No aneurysm was identified. MRI 
brain without contrast (Figure 3) showed no clear source for the observed subarachnoid hemorrhage 
and the brain appeared normal. Transcranial dopplers performed daily over 7 days were negative for 
any significant vasospasm. CTA (Figure 4) after 1 week from onset showed resolution of the SAH 
and possible dissection flaps involving the cavernous portions of bilateral internal carotid arteries 
which ultimately were determined to be bony artifact. 
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Figure 1. CT head showing the SAH upon presentation. 
 
 
Figure 2. CT Angiogram 
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Figure 3. A) MRI brain SWAN sequence the day after presentation. 
 
 
Figure 3 B) MRI T2 Flair sequence
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Figure 4. CTA performed 1 week after onset of symptoms showed possible dissection flaps 
involving the cavernous portions of the internal carotid arteries. This may represent bony artifact. 
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Discussion 
Angiogram negative SAH (or non-aneurysmal SAH) accounts for 15-20% of all SAH2 and is 
believed to be caused by: venous drainage anomalies or venous sinus thrombosis; spinal or 
cerebral dural or parenchymal vascular malformation or tumors in the brain, spine, or 
subarachnoid space; infections; blood dyscrasias, complications of anticoagulants and 
fluoxetine, trauma, and small perforating vessel rupture.2 Our patient may have had a small 
vessel rupture that was not picked up on any of the three angiograms that were performed. 
As per MacKinnon et al, the incidence of spontaneous SAH worldwide is approximately 9 per 
100,000 persons peaking in the sixth decade.3 According to Nayak et al., in their classification 
system (Table 1), Type 1a and 1b SAH which are localized to basal cisterns and sylvian fissure 
only, have benign outcomes, based on their study of 129 type 1 SAH patients.2 Despite the 
likelihood that his prognosis would likely be benign, our patient was not discharged but 
admitted to observation in the hospital because the initial CT imaging raised the possibility of 
an underlying AVM and also because most cases of vasospasm occur on days 3-7. Once the 
MRI brain disproved any AVM,  DSA was employed to not miss any aneurysm which may not 
have been noticed, as sometimes CTA misses a small aneurysm due to various reasons such as 
small aneurysm lumen size, technical factors like poor contrast timing, and large blood burden.4 
Foreman et al reported finding that 4 out of 16 patients retrospectively studied with post-coital 
SAH had no brain pathology.4 
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Table 1. Illustration of the SAH classification categories from Nayak et al.1 
 
Subarachnoid Hemorrhage Types 1-4 Distribution 
Type 1A Blood in Basal Cisterns only 
Type 1B Blood in Basal Cisterns w/ Extension into 
the Sylvian Fissures 
Type 2 Type 1 (1a & 1b) w/ Extension of Blood 
into Cortical Sulci Ventricles 
Type 3 SAH w/out Blood in Basal Cisterns 
Type 4 Any Type of SAH with Subarachnoid blood in 
the Posterior Fossa/Cerebellar Vermis 
 
Non-aneurysmal SAH during sexual activity may be due to high blood pressure affecting 
spiking of mean arterial pressure (MAP) and impacting cerebral autoregulation negatively. 
Also, intercourse leads to elevated heart rate causing a hyperdynamic state.3 Oral erectile 
dysfunction treatment popular nowadays is with phosphodiesterase-5 inhibitors and these have 
been reported to be linked to both aneurysmal and non-aneurysmal SAH, especially during 
their illicit use;5,6,7,8 our patient, however, denied using these medications. 
It would be helpful to have information about further relatives of patient in order to determine 
if there was any possibility of Ehlers-Danlos (EDS) vascular type in the family, however, he 
was lost to follow up. EDS makes one prone to dissection and possibly hemorrhage. The 
angiogram did not indicate any trace of Call – Fleming syndrome either, also known as 
reversible vasoconstriction syndrome (RCVS), or of cerebral vasculitis which may cause acute 
headache. 
Patient’s cannabis habit may have been a risk factor because vasoactive substance use may 
contribute to a subarachnoid hemorrhage. Rumalla et al reported that recreational marijuana use 
is independently associated with an increased likelihood of SAH.9 The incidence of a SAH 
among cannabis users was 10.67 times greater than expected when adjusted for age, 13.20 
times greater than expected when adjusted for gender, and 8.71 times greater than expected 
when adjusted for race.9 This fact is not widely known, and further studies are needed. 
The main psychoactive component of cannabis (tetrahydrocannbinol) effects mitochondria and 
oxidative stress, while cannabis cessation showed resolution of multifocal intracranial stenosis 
in 21% of young patients in a series with stroke.10 Transcranial doppler (TCD) studies have 
shown elevated cerebrovascular resistance in cannabis users, which may increase 
susceptibililty to delayed cerebral ischemia, along with elevated systolic velocities.10 Curiously 
our patient did not have concerning TCD results. He did not have any striking structural 
differences on vascular imaging (Figure 2, Figure 4) so there may still be an unknown 
component that contributed to his presentation and worked in combination with his vasoactive 
substance use, with the rapid increase in blood pressure and heart rate which occur in 
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intercourse, to cause his angiogram- negative SAH. 
 
The take away points and conclusions that come to mind with this case are that given that 
Rumalla et al saw a risk of an 18%  increase for SAH correlating to cannabis, which is not 
insignificant, caution should be exercised when using vasoactive substances in the setting of 
activities that already act to increase heart rate and blood pressure naturally, as does intercourse.  
So perhaps when taking social history physicians could consider counselling marijuana users to 
take care, or at least be informed about their risk for rare but potentially grave neurologic 
consequences, the mechanism of which is not fully understood. With legalization of medical and 
in some states recreational marijuana, it is useful to present this case for discussion.  Certain 
corollaries exist; for example, valsalva manouvers have occasionally been linked to aneurysmal 
rupture and straining when constipated may potentially increase intracranial pressure, but there 
are many factors at work as to why sometimes a serious complication results. Similarly, it is 
conceivable that blood redistribution and cerebrovascular resistance may play a role in causing 
SAH when vasovagal substances like marijuana are used but there may be other understudied or 
unknown predictors.   
 
The rationale for these conclusions is that while this patient had no long lasting repercussions, it 
was still a serious encounter that could have had dire consequences.  He was an otherwise 
normal young male with the only risk factor of stroke being smoking. It could have turned out 
quite differently for another patient in a similar situation who had more vascular risk factors, or 
at another time for this same patient if he combined another vasovagal drug with the marijuana.  
Essentially, further study is needed on this subject, preferably as a case series.  Cannabis has had 
a long history of use in the world, so it may be useful to keep track of similar cases of non-
aneurysmal post-coital SAH coinciding with marijuana use, if they can be amassed, although 
they may be rather under-reported due to the sensitive and divisive nature of the topic. 
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